Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2026-08-31 20:15:24 ET · period of report 2026-08-31 · accession 0002043395-26-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-31 20:15 | 2026-08-31 | FENC | Sayad Pierre Sargis | Chief Medical Off | A - Grant | $0.00 | +168 | 21.5K | +0.8% | $0 | |
| 2026-08-31 20:15 | 2026-08-31 | FENC | Sayad Pierre Sargis | Chief Medical Off | S - Sale | $12.18 | -12.0K | 9,519 | -56% | -$146.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2026-08-31 | A | A | 168 | $0.00 | 21,519 | D | — | — | (F1) Represents shares released from restriction from shares awarded 3/28/2025. |
| 2 | Common | Common Shares | 2026-08-31 | S | D | 12,000 | $12.18 | 9,519 | D | — | — | (F2) Represents sale of previously vested restricted shares and vested performance shares. |